Shenzhen S.E.
06:00:00 2024-04-23 pm EDT
5-day change
1st Jan Change
3.77
CNY
-0.26%
+0.80%
-15.09%
Guizhou Xinbang Pharmaceutical Co., Ltd. acquired remaining 4.52% stake in Jiangsu Xinbang Pharmaceutical Co., Ltd. from Changzhou Oriental Bio-Engineering Co., Ltd.
March 14, 2014 at 12:00 am EDT
Guizhou Xinbang Pharmaceutical Co., Ltd. (SZSE:002390) acquired remaining 4.52% stake in Jiangsu Xinbang Pharmaceutical Co., Ltd. from Changzhou Oriental Bio-Engineering Co., Ltd. in September, 2013.
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Apr. 15
CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Apr. 01
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Board Appointments
Feb. 21
CI
Xinbang Pharma Chairman Buys 14 Million Yuan More Shares
Jan. 04
MT
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
Jan. 03
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
23-10-29
CI
Tranche Update on Guizhou Xinbang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on July 14, 2023.
23-10-09
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
23-08-28
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. commences an Equity Buyback Plan for 14,705,882 shares, representing 0.76% for CNY 200 million, under the authorization approved on July 13, 2023.
23-07-14
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. authorizes a Buyback Plan.
23-06-26
CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component Index
23-06-09
CI
Guizhou Xinbang Pharmaceutical Co., Ltd.(SZSE:002390) dropped from Shenzhen Stock Exchange Component A Share Index
23-06-09
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023
23-05-24
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Final Dividend for 2022
23-05-15
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
23-04-28
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Proposes Final Dividend for 2022
23-04-18
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
23-04-17
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022
22-10-28
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022
22-08-24
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Implementation of Final Cash Dividend for 2021, Payable on 24 May 2022
22-05-18
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Approves Cash Dividend
22-05-09
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
22-04-29
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Announces Final Cash Dividend Proposal for 2021
22-04-15
CI
Guizhou Xinbang Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
22-04-14
CI
Guizhou Kekai Medicine Co., Ltd. announced that it expects to receive CNY 461.450506 million in funding from Guizhou Xinbang Pharmaceutical Co., Ltd.
21-11-05
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
GUIZHOU XINBANG PHARMACEUTICAL Co., LTD is a China-based company, principally engaged in the research and development, manufacture and distribution of medical products. The Company operates its businesses through three segments. The Pharmaceutical Manufacturing segment is engaged in the manufacture and distribution of Chinese patent medicines, such as Ginkgo Leaves Tablets. The Pharmaceutical Distribution segment includes rapid wholesale business and medicine retail business. The Medical Services segment is engaged in the provision of medical services. It operates its businesses primarily in domestic markets.
More about the company
1st Jan change
Capi.
-15.09% 995M +38.08% 6.01B -16.43% 4.47B -12.46% 3.11B -0.21% 3.01B -0.59% 2.6B +34.54% 1.85B +0.93% 1.66B -10.63% 1.63B -12.50% 1.53B
Alternative Medicine
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
GUIZHOU XINBANG PHARMACEUTICAL CO., LTD. 
